This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
When obesity has become a national health crisis caused by overeating and lack of exercise, a body positivity website has created free “Don’t Weigh Me” cards for patients who find stepping on the scale at the doctor’s office stressful. The group supports a “Health at Every Size” philosophy, based around the assumption that “the current practice of linking weight to health using BMI (body mass Index) standards is biased and unhelpful.” An analysis p
Johnson & Johnson’s much-touted crop of bispecific antibodies for cancer generated its first commercial product in May, and the drugmaker has now filed for FDA approval of a second candidate. The latest to reach the regulatory stage is teclistamab, one of two bispecifics for multiple myeloma in the late-stage pipeline of J&J’s Janssen division stemming from its longstanding and fertile collaboration with Danish biotech Genmab.
Each year, Google reveals its annual list of top food searches, which are representative of the most popular food trends and recipes of the year. With half of this year’s list stemming from either celebrities or social media, it is clear that “going viral” has a major impact on what consumers are searching for. Here are the top ten food searches from Google in 2021 and what they reveal about the current status of the food and beverage industry.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
The demand quickly exceeded supply after the FDA approved once-weekly semaglutide injections. Semaglutide’s study results were enough to warrant plenty of hype for obesity treatment. The drug got a PR boost from Marc Andreessen, who called semaglutide a “silver bullet” and “miracle drug” for suppressing appetite. Unfortunately, the hype is going to exceed reality.
This chart shows the pharmaceutical companies with the most patents in Spain. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Spain? appeared first on DrugPatentWatch - Make Better Decisions.
The Coronavirus SARS-CoV-2 infects the kidneys and contributes to tissue scarring, as shown by researchers from the RWTH Uniklinik Aachen, Germany, and Radboudumc, The Netherlands. The developed scar tissue in the infected kidneys may suggest a possible impact on kidney outcomes in the long term. Credit: Jitske Jansen and Bart Smeets, Radboudumc The Coronavirus SARS-CoV-2 […].
The Coronavirus SARS-CoV-2 infects the kidneys and contributes to tissue scarring, as shown by researchers from the RWTH Uniklinik Aachen, Germany, and Radboudumc, The Netherlands. The developed scar tissue in the infected kidneys may suggest a possible impact on kidney outcomes in the long term. Credit: Jitske Jansen and Bart Smeets, Radboudumc The Coronavirus SARS-CoV-2 […].
Routine cancer screening is essential to detect cancers early when it is most curable. The consequence of millions of people missing cancer screenings because of the COVID pandemic is a delay in detecting cancer, which results in cancer progressing to a more advanced stage. According to a study published in JAMA Oncology, a publication of the American Medical Association, nearly 22 million cancer screenings in the U.S. failed to happen because of the COVID-19 pandemic.
This cohort study compares COVID-19 incidence, risk, outcome severity, and treatment response between immunocompromised individuals and those without immune dysfunction conditions before and after SARS-CoV-2 vaccination.
PHILADELPHIA — Penn Medicine has been awarded a prestigious seven-year, $14 million grant from the National Institutes of Health (NIH) to promote organ transplantation for patients with end-stage renal disease who are currently on the waitlist for a kidney transplant. The team will launch a clinical trial harnessing synthetic chimeric antigen receptor (CAR) T cells […].
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The case was the first of its kind, targeting every point of the prescription opioid supply chain, from manufacturers to pharmacy chains that filled prescriptions.
Bayer has announced that all of its products will have 100 percent green packaging by 2030. The pharma giant says it will be investing €100 million towards achieving this target, which is part of the company’s sustainability program aimed at helping to protect the environment and combat climate change. This means all of the company’s over-the-counter (OTC) drugs and supplements such as pain, allergy and cold medications, and vitamins will have brand packaging that is 100 percent recyclable or re
The jury in a new York trial has found that Teva Pharmaceuticals played a role in fuelling the opioid crisis in the US, and should be held liable for damages, which will be decided later. The decision came after eight days of deliberation by the jurors, and almost six months of legal jousting between the drugmaker and its counsel and lawyers for the state of New York and two of its counties, Suffolk and Nassau.
A team of researchers at the University of Adelaide has found a link between the way that cells produce energy for brain function and the mutated genes found in Alzheimer’s disease. Credit: Pixabay. Photo by Pete Linforth. A team of researchers at the University of Adelaide has found a link between the way that cells […].
Wearable Tech-What’s It All About? Let’s start from the very beginning. What are people talking about when they say “wearables”, “wearable biosensors”, “wearable devices”, or “wearable technology” in clinical trials? In the most basic sense, all these terms refer to relatively mobile devices that you can wear on your person; designed to measure specific biological parameters in your body.
Central’s Chrismon Tree began in 1977, when the women of the church made the first ornaments for our church tree. The number of Christian Christmas symbols on our tree has grown each year until we now have over one hundred. Our Chrismons are made in white, the liturgical color of Christmas, which refers to Christ’s purity and perfection, and gold, which refers to his majesty and glory.
In one of the most exciting developments in astronomy in the 21st century, NASA is launching the James Webb Space Telescope (JWST) today—and Northern Arizona University astronomers, planetary astronomers and their students will be using the massive observatory to expand their research and advance our understanding of the solar system. Credit: Credit: Ball Aerospace In […].
Un tratamiento que puede ayudar a la gente que necesita anteojos para ver de cerca, sin afectar su visión de largo alcance, salió al mercado en diciembre tras ser aprobado por la FDA en octubre.
This chart shows the pharmaceutical companies with the most patents in Slovenia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Slovenia? appeared first on DrugPatentWatch - Make Better Decisions.
2022! A fresh year, we hope. A new start, we pray. A chance to leave past pain and struggle in the past. But what are we moving toward? What are our dreams and aspirations, especially as a community of faith? Dare we ask what are God’s dreams for us as a community of faith? Our theme for 2022 is “Jesus 365.” We begin the year with a journey through Luke’s gospel, picking up the story this Sunday when Jesus is 12 years old and left behind in Jerusalem.
Cylindrical vector beam (CVB) multiplexing has emerged as a powerful technique to boost signal channels. Coupling and separating CVBs are two pivotal elements in CVB multiplexing communication. Although off-axis control technologies, such as miniature Dammann vortex gratings, have been investigated to couple and separate light beams, it is usually limited to light beams with homogeneous […].
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
[![bortezomib structure]([link] Bortezomib is the generic ingredient in two branded drugs marketed by Takeda Pharms Usa, Dr Reddys Labs Ltd, and Fresenius Kabi Usa and, and is included in three…. The post New tentative approval for Hospira Inc drug bortezomib appeared first on DrugPatentWatch - Make Better Decisions.
We’ve likely all experienced beautiful sunrises in various places. Perhaps a never-ending ocean? An expansive high desert where one can see forever? A peaceful Smoky Mountain lookout? The broad Texas or Oklahoma plains? Your own backyard with multicolored sky? We’re reminded that day is not ending, but gloriously beginning. “O Holy Night” gives us imagery of the first Advent with the line, “for yonder breaks a new and glorious morn.
Dementia is thought to occur when proteins called amyloid-?, tau, and ?-synuclein accumulate in the brain and form oligomers. A research group from the Department of Translational Neuroscience, Osaka City University Graduate School of Medicine, had previously shown in a study using mice that the antibiotic rifampicin removes oligomers from the brain and improves cognitive […].
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing Leonhardt Ventures Announces Filing of Patent for Bioelectric S100A Expression for Organ Healing Mission Viejo, California, United States, Dec.
Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in two NDAs. It is available from one supplier. There are seven patents…. The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPatentWatch - Make Better Decisions.
But those who hope in the Lord will renew their strength. They will soar on wings like eagles; they will run and not grow weary, they will walk and not be faint. Isaiah 40:30 NIV This is my God story – a story of His peace, His love, and my hope. My hope was in the Lord during a long difficult journey of recovery and rehabilitation after a near-fatal car accident.
UCL press release Under embargo until Wednesday 29 December, 22:00 UK time / 17:00 US Eastern time Credit: Picturing Health, picturinghealth.org UCL press release Under embargo until Wednesday 29 December, 22:00 UK time / 17:00 US Eastern time Peer-reviewed / Randomised controlled trial / People Easy-to-take medicine better at suppressing HIV in children A once-a-day […].
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
43 
Let's personalize your content